Skip to main content
Caplight Logo









Edesa Biotech Inc

Edesa Biotech Inc

Public

Edesa Biotech Inc is now publicly traded

The data on this page reflects Edesa Biotech Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jun 16, 2026

Total Funding Raised

$25.25M

Company Overview

Edesa Biotech Inc operates in Healthcare and is based in Canada. It has raised $25.25M.

Edesa Biotech Inc is a clinical-stage biopharmaceutical company that develops targeted therapies for inflammatory and immune-related diseases.

Sector

Healthcare

AI Layer

Non-AI

Edesa Biotech Inc Comparables

Compare Edesa Biotech Inc with similar companies based on industry and business-model similarity.

No comparables are published for Edesa Biotech Inc. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Edesa Biotech Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJun 16, 2026
Private PlacementFeb 12, 2025
Private PlacementJul 6, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Peter W.

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Edesa Biotech Inc Filings

Explore SEC and related filing metadata, where available.

Edesa Biotech Inc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

HeadquartersCanada
Employee Range22
Year Founded2015
Last FundingJun 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?